Patents by Inventor Daniel Buck

Daniel Buck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10918816
    Abstract: A compliance monitoring module for a breath-actuated inhaler comprising: a miniature pressure sensor, a sensor port of said sensor being pneumatically coupled to a flow channel through which a user can inhale; a processor configured to: receive a signal originating from a dosing mechanism of the inhaler indicating that medication has been released; receive data from a sensing element of the sensor; and based on said signal from said dosing mechanism and said data from said sensing element, make a determination that inhalation of a breath containing medication through said flow channel complies with one or more predetermined requirements for successful dosing; and a transmitter configured to, responsive to said determination, issue a dosing report.
    Type: Grant
    Filed: October 1, 2018
    Date of Patent: February 16, 2021
    Assignee: Norton (Waterford) Limited
    Inventors: Mark Steven Morrison, Douglas E. Weitzel, Enrique Calderon Oliveras, Daniel Buck
  • Patent number: 10905356
    Abstract: A compliance monitoring module for an inhaler comprising: a miniature pressure sensor, a sensor port of said sensor being configured to be pneumatically coupled to a flow channel of said inhaler through which a user can inhale; a processor configured to: receive data from a sensing element of the pressure sensor; receive data from a mode sensor configured to detect when the inhaler changes from an inactive mode to an active mode; and based on said data from said pressure sensor sensing element and said data from said mode sensor, compile a compliance report; and a transmitter configured to issue said compliance report.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: February 2, 2021
    Assignee: Norton (Waterford) Limited
    Inventors: Mark Steven Morrison, Douglas E. Weitzel, Enrique Calderon Oliveras, Daniel Buck
  • Publication number: 20210016026
    Abstract: An inhaler includes a main body having a canister housing, a medicament canister retained in a central outlet port of the canister housing, and a dose counter having an actuation member for operation by movement of the medicament canister. The canister housing has an inner wall, and a first inner wall canister support formation extending inwardly from a main surface of the inner wall. The canister housing has a longitudinal axis X which passes through the center of the central outlet port. The first inner wall canister support formation, the actuation member, and the central outlet port lie in a common plane coincident with the longitudinal axis X such that the first inner wall canister support formation protects against unwanted actuation of the dose counter by reducing rocking of the medicament canister relative to the main body of the inhaler.
    Type: Application
    Filed: June 29, 2020
    Publication date: January 21, 2021
    Inventors: Declan Walsh, Derek Fenlon, Simon Kaar, Jan Geert Hazenberg, Daniel Buck, Paul Clancy, Robert Charles Uschold, Jeffrey A. Karg
  • Publication number: 20210016027
    Abstract: A breath actuated metered dose inhaler may comprise a canister fire system configured to fire a medicament containing canister in response to patient inhalation. The canister fire system may comprise a pneumatic force holding unit and having a rest configuration in which a metering valve of the canister is in a refill configuration; a prepared configuration in which a canister actuation force is retained by the pneumatic force holding unit and the canister fire system is actuatable by patient inhalation induced airflow; and a fire configuration in which the metering valve is in a dose delivery position. When in the prepared configuration, the force retained by the pneumatic force holding unit may be reduced by less than about 6% over a period of 5 minutes, preferably less than about 3% over a period of 5 minutes.
    Type: Application
    Filed: October 2, 2020
    Publication date: January 21, 2021
    Applicant: Norton (Waterford) Limited
    Inventors: Declan Walsh, Paul Prendergast, Daniel Buck, Trevor Kent, Niall Thompson
  • Publication number: 20200360630
    Abstract: A system may include an external device and an inhaler. The external device may include a processor, a communication circuit, and memory. The inhaler may include a mouthpiece, medicament, a mechanical dose counter, and an electronics module comprising a processor and a communication circuit. The electronics module may record a dosing event when the inhaler is actuated, such as when the mouthpiece cover is opened, and send a signal indicating the dosing event to the external device. The external device may receive a mechanical dose reading of the mechanical dose counter, determine an electronic dose reading based on the signal indicating the dosing event, determine that a discrepancy between the mechanical dose reading and the electronic dose reading exceeds a threshold, and notify the user of the discrepancy, for example, by providing a notification to the user by way of a mobile application residing on the external device.
    Type: Application
    Filed: May 15, 2020
    Publication date: November 19, 2020
    Applicant: Norton (Waterford) Limited
    Inventors: Enrique Calderon Oliveras, Daniel Buck
  • Patent number: 10821088
    Abstract: The present invention relates to TRPV1 selective agonist topical compositions including capsaicinoid and analgesic agent compositions and methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Grant
    Filed: September 10, 2014
    Date of Patent: November 3, 2020
    Assignee: PROPELLA THERAPEUTICS, INC.
    Inventors: Daniel Bucks, Philip J. Birbara
  • Publication number: 20200323800
    Abstract: The present invention relates to TRPV1 selective agonist compositions including a capsaicinoid, a surfactant and an extended release agent, and to methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Application
    Filed: January 16, 2020
    Publication date: October 15, 2020
    Inventors: Philip J. BIRBARA, Daniel Bucks
  • Patent number: 10792447
    Abstract: A breath actuated metered dose inhaler may include a canister fire system configured to fire a medicament containing canister in response to patient inhalation. The canister fire system may include a pneumatic force holding unit and having a rest configuration in which a metering valve of the canister is in a refill configuration; a prepared configuration in which a canister actuation force is retained by the pneumatic force holding unit and the canister fire system is actuatable by patient inhalation induced airflow; and a fire configuration in which the metering valve is in a dose delivery position. When in the prepared configuration, the force retained by the so pneumatic force holding unit may be reduced by less than about 6% over a period of 5 minutes, preferably less than about 3% over a period of 5 minutes.
    Type: Grant
    Filed: January 25, 2019
    Date of Patent: October 6, 2020
    Assignee: NORTON (WATERFORD) LIMITED
    Inventors: Declan Walsh, Paul Prendergast, Daniel Buck, Trevor Kent, Niall Thompson
  • Patent number: 10695512
    Abstract: An inhaler includes a main body having a canister housing, a medicament canister retained in a central outlet port of the canister housing, and a dose counter having an actuation member for operation by movement of the medicament canister. The canister housing has an inner wall, and a first inner wall canister support formation extending inwardly from a main surface of the inner wall. The canister housing has a longitudinal axis X which passes through the center of the central outlet port. The first inner wall canister support formation, the actuation member, and the central outlet port lie in a common plane coincident with the longitudinal axis X such that the first inner wall canister support formation protects against unwanted actuation of the dose counter by reducing rocking of the medicament canister relative to the main body of the inhaler.
    Type: Grant
    Filed: November 6, 2017
    Date of Patent: June 30, 2020
    Assignees: Ivax Pharmaceuticals Ireland, Norton (Waterford) Limited, Teva Pharmaceuticals Ireland
    Inventors: Declan Walsh, Derek Fenlon, Simon Kaar, Jan Geert Hazenberg, Daniel Buck, Paul Clancy, Robert Charles Uschold, Jeffrey A. Karg
  • Publication number: 20200155215
    Abstract: A cryoprotectant for use with a treatment device for improved removal of heat from subcutaneous lipid-rich cells of a subject having skin is provided. The cryoprotectant is a non-freezing liquid, gel, or paste for allowing pre-cooling of the treatment device below 0° C. while preventing the formation of ice thereon. The cryoprotectant may also prevent freezing of the treatment device to the skin or ice from forming from moisture seeping out from the skin. The cryoprotectant may further be hygroscopic, thermally conductive, and biocompatible.
    Type: Application
    Filed: October 8, 2019
    Publication date: May 21, 2020
    Inventors: Mitchell E. Levinson, Donald Johnson, Jessica Preciado, Edward A. Ebbers, Daniel Bucks
  • Publication number: 20200129711
    Abstract: The present disclosure describes an inhaler for the inhalation of powder medication. The inhaler has a body and at least one reservoir containing powder medication, the body having an air inlet and an outlet for the transmission to a patient of air entering the body through the air inlet and powder medication. The outlet has a total cross-sectional area for flow which is more than 80% of the total cross-sectional area of the air inlet.
    Type: Application
    Filed: January 16, 2018
    Publication date: April 30, 2020
    Applicant: NORTON (WATERFORD) LIMITED
    Inventor: Daniel Buck
  • Patent number: 10583100
    Abstract: The present invention relates to TRPV1 selective agonist compositions including a capsaicinoid, a surfactant and an extended release agent, and to methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Grant
    Filed: January 9, 2019
    Date of Patent: March 10, 2020
    Assignee: VIZURI HEALTH SCIENCES LLC
    Inventors: Philip J. Birbara, Daniel Bucks
  • Patent number: 10569034
    Abstract: A compliance monitoring module for a breath-actuated inhaler comprising: a miniature pressure sensor, a sensor port of said sensor being pneumatically coupled to a flow channel through which a user can inhale; a processor configured to: receive a signal originating from a dosing mechanism of the inhaler indicating that medication has been released; receive data from a sensing element of the sensor; and based on said signal from said dosing mechanism and said data from said sensing element, make a determination that inhalation of a breath containing medication through said flow channel complies with one or more predetermined requirements for successful dosing; and a transmitter configured to, responsive to said determination, issue a dosing report.
    Type: Grant
    Filed: August 18, 2017
    Date of Patent: February 25, 2020
    Assignee: Norton (Waterford) Limited
    Inventors: Mark Steven Morrison, Douglas E. Weitzel, Enrique Calderon Oliveras, Daniel Buck
  • Patent number: 10561808
    Abstract: A dose counter for an inhaler includes a counter display arranged to indicate dosage information, and a drive system arranged to move the counter display incrementally in a first direction from a first station to a second station in response to actuation input. A regulator is provided which is arranged to act upon the counter display at the first station to regulate motion of the counter display at the first station to incremental movements.
    Type: Grant
    Filed: September 12, 2016
    Date of Patent: February 18, 2020
    Assignees: IVAX PHARMACEUTICALS IRELAND, NORTON (WATERFORD) LIMITED, TEVA PHARMACEUTICALS IRELAND
    Inventors: Declan Walsh, Derek Fenlon, Simon Kaar, Jan Geert Hazenberg, Daniel Buck, Paul Clancy, Robert Charles Uschold, Jeffrey A. Karg
  • Publication number: 20200009335
    Abstract: An inhaler includes a mouthpiece cover, a pressure sensor, a first indicator and a second indicator. The first indicator may be configured to indicate based on a state of the cover, and the second indicator may be configured to indicate based on an output of the pressure sensor. For example, when the mouthpiece cover opens, the first indicator may illuminate and a dose of medication may be transferred from a reservoir to a dosing cup. The second indicator may illuminate if an amount of inhaled medication reaches a predetermined threshold for successful inhalation.
    Type: Application
    Filed: September 16, 2019
    Publication date: January 9, 2020
    Applicant: Norton (Waterford) Limited
    Inventors: Enrique Calderon Oliveras, Daniel Buck, Frederic Scott Fleming, Douglas E. Weitzel
  • Patent number: 10463816
    Abstract: An inhaler includes a mouthpiece cover, a pressure sensor, a first indicator and a second indicator. The first indicator may be configured to indicate based on a state of the cover, and the second indicator may be configured to indicate based on an output of the pressure sensor. For example, when the mouthpiece cover opens, the first indicator may illuminate and a dose of medication may be transferred from a reservoir to a dosing cup. The second indicator may illuminate if an amount of inhaled medication reaches a predetermined threshold for successful inhalation.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: November 5, 2019
    Assignee: Norton (Waterford) Limited
    Inventors: Enrique Calderon Oliveras, Daniel Buck, Frederic Scott Fleming, Douglas E. Weitzel
  • Publication number: 20190262602
    Abstract: A breath actuated metered dose inhaler may comprise a canister fire system configured to fire a medicament containing canister in response to patient inhalation. The canister fire system may comprise a pneumatic force holding unit and having a rest configuration in which a metering valve of the canister is in a refill configuration; a prepared configuration in which a canister actuation force is retained by the pneumatic force holding unit and the canister fire system is actuatable by patient inhalation induced airflow; and a fire configuration in which the metering valve is in a dose delivery position. When in the prepared configuration, the force retained by the pneumatic force holding unit may be reduced by less than about 6% over a period of 5 minutes, preferably less than about 3% over a period of 5 minutes.
    Type: Application
    Filed: January 25, 2019
    Publication date: August 29, 2019
    Applicant: Norton (Waterford) Limited
    Inventors: Declan Walsh, Paul Prendergast, Daniel Buck, Trevor Kent, Niall Thompson
  • Patent number: 10391267
    Abstract: A method of manufacturing a series of incremental dose counters for inhalers, which includes manufacturing the dose counters with nominal canister fire and dose count positions of a dose counter actuator relative to a dose counter chassis or inhaler main body, and which includes building the dose counters with an average dose count position in the series being, in canister fire process, at or after an average canister fire position in the series.
    Type: Grant
    Filed: May 15, 2015
    Date of Patent: August 27, 2019
    Assignees: IVAX PHARMACEUTICALS IRELAND, TEVA PHARMACEUTICALS IRELAND, NORTON (WATERFORD) LIMITED
    Inventors: Declan Walsh, Derek Fenlon, Simon Kaar, Jan Geert Hazenberg, Daniel Buck, Paul Clancy, Robert Charles Uschold, Jeffrey A. Karg
  • Publication number: 20190247337
    Abstract: The present invention relates to TRPV1 selective agonist compositions including a capsaicinoid, a surfactant and an extended release agent, and to methods of manufacture and methods of providing pain relief as well as treating a variety of disorders with such compositions.
    Type: Application
    Filed: January 9, 2019
    Publication date: August 15, 2019
    Inventors: Philip J. BIRBARA, Daniel BUCKS
  • Publication number: 20190167926
    Abstract: A nasal inhaler for the inhalation of inhalable substances comprise: a canister having an interior reservoir containing pressurised inhalable substances including fluid; a metering valve including a metering chamber and a valve stem defining a communication path between the metering chamber and the interior reservoir, the communication path including an opening configured to permit flow between a transfer space inside the valve stem and the interior reservoir, the interior reservoir being arranged for orientation above the metering chamber whereby gas located within the metering chamber is replaced with liquid from the interior reservoir.
    Type: Application
    Filed: February 7, 2019
    Publication date: June 6, 2019
    Applicant: Norton (Waterford) Limited
    Inventors: Daniel Buck, Paul Prendergast, Declan Walsh